Home Cart Sign in  
Chemical Structure| 2765218-56-0 Chemical Structure| 2765218-56-0

Structure of PY-60
CAS No.: 2765218-56-0

Chemical Structure| 2765218-56-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PY-60 is a small molecule agonist that selectively activates annexin A2 (ANXA2) transcriptional activity (Kd=1.4 μM). By directly binding to ANXA2, PY-60 antagonizes its inhibition of YAP activity, demonstrating potential applications in cancer treatment.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PY-60

CAS No. :2765218-56-0
Formula : C16H15N3O2S
M.W : 313.37
SMILES Code : O=C(C1=NOC(C2=CC=CC=C2)=C1)NCCCC3=NC=CS3
MDL No. :MFCD34474253

Safety of PY-60

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of PY-60

Hippo

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293A cells 10 µM 2 to 24 h At least 16 h of continuous PY-60 exposure was required for maximal induction of YAP transcriptional response. PMC10334740
primary adult human epidermal keratinocytes (HEKa) 10 µM 24 h PY-60 induced a robust YAP-driven transcriptional program, reducing terminal differentiation and apoptosis of keratinocytes and increasing proliferative capacity. PMC10334740
HK-2 cells 10 μM 24 h PY-60 increased the expression of Nrf2, while YAP1 knockdown counteracted the effect of TMP on autophagic flux. PMC11781175
Mouse primary hepatocytes 1.6 µm 6 h PY-60 significantly inhibited H/R-induced apoptosis in RAMP1-KO primary hepatocytes by suppressing YAP phosphorylation. PMC11022058
NCI-H358 cells 10 µM 24 h To examine the effect of PY-60 on the Hippo pathway, results showed PY-60 increased YAP protein levels and inhibited its phosphorylation PMC11895337
A-549 cells 10 µM 24 h To examine the effect of PY-60 on the Hippo pathway, results showed PY-60 increased YAP protein levels and inhibited its phosphorylation PMC11895337

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Yucatan mini pig Partial and full thickness wound models Topical application 0.15 wt% gel Every other day for 8 days PY-60 significantly accelerated the closure of partial and full thickness wounds, increasing the thickness of both epidermal and dermal layers. PMC10334740
Mice 70% liver ischemia-reperfusion model in RAMP1-KO mice Intraperitoneal injection 10 mg/kg Single dose, lasting 6 hours PY-60 significantly alleviated liver ischemia-reperfusion injury by inhibiting YAP phosphorylation and reducing hepatocyte apoptosis. PMC11022058

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.19mL

0.64mL

0.32mL

15.96mL

3.19mL

1.60mL

31.91mL

6.38mL

3.19mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories